Nurix Therapeutics (NRIX) Net Cash Flow Growth (1y) (2020 - 2026)
Nurix Therapeutics (NRIX) Net Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 301.06% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - | -142.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -142.07% |
| Feb 28, 2026 | -415.73% |
| Nov 30, 2025 | 1,438.59% |
| Aug 31, 2025 | 67.57% |
| May 31, 2025 | -87.54% |
| Feb 28, 2025 | -607.96% |
| Nov 30, 2024 | -11.12% |
| Aug 31, 2024 | -6.56% |
| May 31, 2024 | 163.82% |
| Feb 29, 2024 | 84.42% |
| Nov 30, 2023 | -27.16% |
| Aug 31, 2023 | -376.51% |
| May 31, 2023 | 168.16% |
| Feb 28, 2023 | -2,681.55% |
| Nov 30, 2022 | 125.28% |
| Aug 31, 2022 | 114.82% |
| May 31, 2022 | -160.24% |
| Feb 28, 2022 | -115.81% |
| Nov 30, 2021 | 54.21% |
| Aug 31, 2021 | -138.28% |